The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use counterfeit semaglutide 1.0 milligrams — the Ozempic injection — found in the U.S. drug supply ...

Lot number PAR0362 with serials starting 51746517 flagged as counterfeit Ozempic. FDA links five non ... Additionally, the analysis found the needles from the samples were counterfeit.

Novo Nordisk cautions pharmacies and individuals to only purchase Ozempic® (semaglutide) injection 1 mg and ... were found to include counterfeit needles, which means the FDA could not certify ...

On Monday, Novo Nordisk A/S (NYSE:NVO) said it had become aware of several hundred units of Ozempic (semaglutide) injection 1 mg ... the analysis found the needles from the samples were counterfeit.

Some of the fraudulent products include counterfeit needles ... the maker of Ozempic and the weight loss drug Wegovy, stating that fake 1-milligram injections were being distributed outside ...

On Monday, Novo Nordisk A/S (NYSE:NVO) said it had become aware of several hundred units of Ozempic (semaglutide) injection 1 mg distributed outside ... Additionally, the analysis found the needles ...

Ozempic has been used off-label by people seeking to lose weight. The retail price is $998 for four injections to be used weekly. Wegovy is the company's weight loss drug, which also is an injectable.

Patients are encouraged to only acquire authentic Novo Nordisk Ozempic ® (semaglutide) injection 1 mg through pharmacies and to check the product for any signs of counterfeiting before using.

PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic ® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized ...

The latest data puts Lilly firmly in the lead in the race for effective oral drugs that can compete with injections. Ozempic, approved for diabetes in 2017, is designed to target an intestinal ...